Cascade Investment Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Cascade Investment Advisors's NVO Position: Q2 2023 in Review
Cascade Investment Advisors sold out of Novo Nordisk (NVO) in Q2 2023, closing a stake of 440 shares — an estimated $35K sold.
Cascade Investment Advisors first reported a position in NVO in Q2 2016 and held it in 25 quarters. The position peaked at $35K in Q1 2023. 1,196 funds tracked by Wall St. Rank hold NVO as of Q2 2023.
- Cascade Investment Advisors reported no remaining Novo Nordisk position as of Q2 2023 after selling out during the quarter.
- Cascade Investment Advisors sold 440 Novo Nordisk shares in Q2 2023, an estimated $35K.
- Cascade Investment Advisors first reported a position in Novo Nordisk in Q2 2016 and held it in 25 quarters.
- Cascade Investment Advisors's Novo Nordisk position peaked at $35K in Q1 2023.
- 1,196 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.
Based on Cascade Investment Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.